Plain English Summary
Background and study aims
Depression after birth is a disorder of pregnant women, manifesting itself with a depressed
mood, insomnia or somnolence, marked weight loss, psychomotor retardation, a lowered
self-esteem and self-worth, and suicidal thoughts. To decrease the possible depression rates
several approaches were studied. Epidural analgesia is one of them. Epidural analgesia is a
commonly used method in the world to reduce the pain of the pregnant women during labor and is well tolerated by both the mother and the infant. In this study, our primary aim was that the women who had epidural labor analgesia would have lower depression severity scores in the sixth postpartum week. Our secondary aim was that those patients would have lower pain scores during the labor and in at 24th hour if they received epidural analgesia. Our study covered 6 months’ time. The patients were assigned to two groups. One group consisted of the women who gave birth without receiving an epidural analgesia and the other group consisted of women who gave birth with epidural analgesia. Prior to birth and in the 6th week after birth, depression scales were administered to all patients. The patients' severity of the pain was assessed by scales the labor and in the 24th hour postoperatively. In conclusion, our study identified favorable pain scores and lower depression severity in the 6th weeks after birth for patients who received epidural analgesia. In addition, we reported that the increased scores of pains at labor were correlated with postpartum depression. In the light of these results, we suggest that pregnant women should prefer epidural analgesia if they are going to give birth via the normal vaginal route.
Who can participate?
The women at 18-45 years of age, who would give birth electively via normal vaginal route with or without epidural analgesia, who had ASA scores of I-III, and who consented to participate were included in the study
What does the study involve?
Patients were divided into two groups. One group consisted of the women who gave birth without receiving an epidural analgesia and the other group consisted of women who gave birth with epidural analgesia. Prior to birth and in the 6th week after birth, depression scales were administered to all patients. The patients' severity of the pain was assessed by scales the labor and in the 24th hour postoperatively
What are the possible benefits and risks of participating?
There was no risk for the participants because it wats an observational study.
Where is the study run from?
İstanbul Education and Research Hospital, Istanbul (Turkey)
When is the study starting and how long is it expected to run for?
From 25/03/2018 to 25/10/2018
Who is funding the study?
İstanbul Education and Research Hospital, Istanbul
Who is the main contact?
Dr. İpek S. Edipoglu
dripeks@yahoo.com
Study website
Contact information
Type
Scientific
Contact name
Dr Ipek Saadet Edipoglu
ORCID ID
http://orcid.org/0000-0002-3510-5991
Contact details
Telsiz Mahallesi
Balıklı Kazlıçeşme Yolu Cd. No:1
Zeytinburnu/İstanbul
İstanbul
34020
Turkey
Additional identifiers
EudraCT/CTIS number
IRAS number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
A comparison of the severity of postpartum depression in women who gave normal vaginal birth with or without epidural analgesia: a prospective observational study
Acronym
Study hypothesis
Women who have epidural labour analgesia will have lower depression severity scores in the sixth postpartum week. Patients will have lower Visual Analogue Scale (VAS) scores in the 24th hour if they receive epidural analgesia during labour.
Ethics approval(s)
Istanbul Training and Research Hospital Anesthesiology department institutional ethics committee approved the study, 08/02/2018.
Study design
Single centered, prospective, observational
Primary study design
Observational
Secondary study design
Cohort study
Study setting(s)
Hospital
Study type
Diagnostic
Patient information sheet
Not available in web format, please use the contact details below to request a participant information sheet’
Condition
Postpartum depression
Intervention
From the patients who agreed to participate, one group consisted of the women who gave birth without receiving an epidural analgesia and the other group consisted of women who gave birth with epidural analgesia. The total duration of observation and duration of the follow up was 6 weeks for all patient groups. Prior to birth and in the postpartum 6th week, Edinburgh postnatal depression scale was administered to all patients. The patients' severity of the pain was assessed by Visual analogue scale (VAS) during the labour and in the 24th hour postoperatively.
Intervention type
Drug
Pharmaceutical study type(s)
Phase
Not Applicable
Drug/device/biological/vaccine name(s)
Primary outcome measure
Edinburgh postnatal depression scale scores prior to birth and in the postpartum 6th week,
Secondary outcome measures
Visual Analogue Scale (VAS) scores during labour and at 24th hour
Overall study start date
25/02/2018
Overall study end date
25/11/2018
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Women aged 18 to 45 years old.
2. Would give birth electively via normal vaginal route with or without epidural analgesia
3. ASA scores of I-III
Participant type(s)
Patient
Age group
Adult
Lower age limit
18 Years
Sex
Female
Target number of participants
88
Total final enrolment
92
Participant exclusion criteria
1. History of schizophrenia, bipolar disorder or obsessive-compulsive disorder in the pre-partum period.
2. Haematological disorders contraindicated for regional anaesthesia.
3. Skin infections in the lumbar area.
4. If the route of delivery was required to be switched to a cesarean section.
Recruitment start date
25/03/2018
Recruitment end date
25/10/2018
Locations
Countries of recruitment
Turkey
Study participating centre
İstanbul eğitim ve araştırma hastanesi
Balıklı Kazlıçeşme Yolu Cd. No:1 Zeytinburnu
istanbul
34020
Turkey
Sponsor information
Organisation
istanbul eğitim ve araştırma hastanesi
Sponsor details
Telsiz Mahallesi
Balıklı Kazlıçeşme Yolu Cd. No:1
34020 Zeytinburnu/İstanbul
istanbul
34020
Turkey
Sponsor type
Hospital/treatment centre
Website
ROR
Funders
Funder type
Other
Funder name
investigator initiated and funded
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Planned publication in a high-impact peer-reviewed journal
Intention to publish date
25/11/2019
Individual participant data (IPD) sharing plan
The data sharing plans for the current study are unknown and will be made available at a later date.
IPD sharing plan summary
Data sharing statement to be made available at a later date
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | 01/05/2021 | 13/09/2021 | Yes | No |